Life Tech Acquires AcroMetrix to Gain QC Reagents for Real-Time PCR, other Molecular Dx Assays | GenomeWeb

By Bernadette Toner

Life Technologies this week said that it plans to acquire privately held AcroMetrix, a provider of quality control reagents for clinical laboratories, blood screening centers, and in vitro diagnostic manufacturers.

Life Tech said the deal, for which financial details were not disclosed, will complement its real-time PCR business in the short term and help expand its presence in the broader molecular diagnostics market in the longer term.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.